ScreenerHero

HSCS HeartSciences Inc.

NAS · US · Healthcare · Medical Devices · heartsciences.com
3.770USD-13.53%Mkt Cap: 18.26M $P/E: —

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-EC…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$170.98BUSDP/E 31.7
MDT
Medtronic plc
$111.40BUSDP/E 21.4
SYK
Stryker Corporation
$106.71BUSDP/E 28.8
BSX
Boston Scientific Corporation
$61.14BUSDP/E 17.1
EW
Edwards Lifesciences Corporation
$49.80BUSDP/E 51.5
SHL
Siemens Healthineers AG
$46.31BUSDP/E 19.3
DXCM
DexCom, Inc.
$31.47BUSDP/E 33.1
GEHC
GE HealthCare Technologies Inc.
$29.46BUSDP/E 14.9
PHIA
Koninklijke Philips N.V.
$22.91BUSDP/E 18.7
PHG
Koninklijke Philips N.V.
$23.60BUSDP/E 18.0
STE
STERIS plc
$20.34BUSDP/E 25.5
SOON
Sonova Holding AG
$17.13BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$17.11BUSDP/E 21.8
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
TXG
10x Genomics, Inc.
$10.51BUSD
GMED
Globus Medical, Inc.
$10.26BUSDP/E 19.6
DEMANT
Demant A/S
$9.97BUSDP/E 28.3
BIO
Bio-Rad Laboratories, Inc.
$9.87BUSDP/E 46.7
GKOS
Glaukos Corporation
$9.53BUSD

Key Statistics

Company
Market Cap18.26M USD
Enterprise Value24.62M USD
Revenue (TTM)4.52K USD
Gross Profit2.55K USD
Net Income (TTM)-9.14M USD
Revenue/Share0.0010 USD
Last Price3.770 USD
Fiscal Year EndApr 2026
MR QuarterJul 2026
Employees14
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.46
PEG—
EV/EBITDA-2.60
EV/Revenue5447.26
P/S4609.16
P/B-8.25
EPS (TTM)-3.21
EPS (Forward)-1.75
52W Range
1.63059% of range5.250
52W High5.250 USD
52W Low1.630 USD
Profitability
Gross Margin59.06%
Oper. Margin-139956.68%
EBITDA Margin0.00%
Profit Margin-211666.47%
ROE-4044.00%
ROA-173.71%
Growth
Revenue Growth10.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.43M USD
CapEx (TTM)44.45K USD
FCF Margin-49677.47%
FCF Yield-12.29%
Net Debt3.97M USD
Net Debt/EBITDA-0.42
Balance Sheet
Debt/Equity17.41
Current Ratio0.14
Quick Ratio0.01
Book Value/Sh-0.52 USD
Cash/Share0.0060 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateMay 17, 2024
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.00 USD
Upside (mean)+218.3%
Target Range12.00 USD – 12.00 USD
# Analysts1
Ownership
Shares Out.4.84M
Float3.10M
Insiders15.65%
Institutions3.20%
Short Interest
Short Ratio0.3d
Short % Float0.87%
Short % Out.0.83%
Shares Short39.86K
Short (prev mo.)50.68K
Technical
SMA 503.155 (+19.5%)
SMA 2002.670 (+41.2%)
Beta1.86
S&P 52W Chg14.58%
Avg Vol (30d)169.37K
Avg Vol (10d)153.70K
Technical Indicators
RSI (14)49.2
MACD0.2927
MACD Signal0.3971
MACD Hist.-0.1044
BB Upper5.154 USD
BB Middle4.158 USD
BB Lower3.162 USD
BB Width47.90%
ATR (14)0.5101 USD
Vol Ratio (20d)3.88x